News

Vituro Health featured on Cancer Therapy Advisor

December 20, 2015

On Dec. 20, 2015, Stephen Scionti, M.D., medical director of Vituro Health and founder of the Scionti Prostate Center in Sarasota, Fla., spoke with cancertherapyadvisor.com about the recently FDA-cleared HIFU technology and the importance of patients only receiving the treatment from physicians highly trained with HIFU.

READ MORE

Leading HIFU expert begins U.S.-based program with treatment of first prostate cancer patients

December 7, 2015

Patients with prostate cancer are now being treated with minimally invasive, high intensity focused ultrasound (HIFU) therapy, following the October 2015 U.S. Food and Drug Administration (FDA) regulatory authorization for prostate tissue ablation with the Sonablate HIFU device. The leading U.S. HIFU expert, Vituro Health Medical Director Stephen Scionti, M.D., has begun U.S.-based HIFU procedures.

READ MORE